RBDCOV_EU
@RBDCOV_EU
Followers
129
Following
256
Media
321
Statuses
503
RBDCOV aims to test the efficacy, tolerability, and safety of two new clinical trials against COVID-19. Project funded by the @HorizonEU programme.
Europe
Joined January 2022
🔍 New ReCAP interview! We're talking accessibility in clinical trials & EU projects with Mona Sundnes & Jenny Camaradou, Members of the @RBDCOV_EU Community Advisory Panel. How can we make research more inclusive? Read their insights here ⬇️ 🔗 https://t.co/nFhnbk58Tn
0
2
3
What does the #OneHealth approach mean, and how is #RBDCOV contributing to it?🥼🌏 Preventing and managing threats at their source, promoting a balanced and sustainable response to global challenges that impact all forms of life. 👉Read the full article: https://t.co/gGab3EOgD7
0
3
5
From the RBDCOV team, we wish you a happy and healthy New Year! 🌟 In 2025, we will continue working toward a more inclusive and representative healthcare system👩🔬🔴 #RBDCOV #HappyNewYear #Inclusivity #ClinicalTrials
0
0
3
🔴Last Tuesday, we held our annual CM #RBDCOV at Palau Macaya. #Inclusivity in clinical trials remains a key aspect of this project. We discussed the ethical and technical barriers encountered and agreed on the importance of increasing visibility within the scientific community.
0
1
9
📣 HAPPENING NOW 📣 Today, part of the @EATGx team is in Barcelona participating in a @RBDCOV_EU Science Cafe focused on fostering inclusion in clinical trials. Joan Tallada, CAP member, is sharing his expertise and community perspective! 🗣️👏 #RBDCOV
1
3
6
Are #ClinicalTrials equal? No. Today learning the challenges in immunodeficiency patients and pediatric population @RBDCOV_EU @VeristatCRO @VHIR_
0
1
3
We’re Live at the #ScienceCafé with Pere Soler-Palacín, Beatriz Mothe Pujadas, Joan Tallada and Petra Wuelfroth Join us for the open discussion now! 👇👇 https://t.co/XP2o3tig9P
1
5
7
Can’t be there in person? Join us online! Register here👉 https://t.co/KJTf01G183 Join online 👉 https://t.co/kFQhLIpsIu
#ScienceCafé #Inclusivity #ClinicalTrials
0
2
3
Petra Wuelfroth, innovation manager from @COVend_EU project, will also join the discussion to share insights and challenges in clinical trial management
1
1
1
📢Today’s the day!☕ We will be at @ateneubcn at 5:00 PM for the #RBDCOV Science Café. Join Dr. Pere Soler, Dr. Beatriz Mothe, and Joan Tallada in a critical discussion on the importance of inclusivity in clinical trials and its impact on public health.
1
2
4
🔴☕Next Monday, the 18th, Joan Tallada will complete our Science Café panel! As a member of the RBDCOV Community Advisory Board (CAP) and an active contributor to the @EATGx Joan brings valuable community insights to our conversation. Register now!👉 https://t.co/UuC8gP75VP
0
3
8
Only 4 days left until our #ScienceCafé at @ateneubcn Dr. Pere Soler, Head of the Pediatric Infectious Diseases and Immunodeficiencies Unit at @vallhebron will contribute to the discussion with his expertise in research and clinical care. Register now👉 https://t.co/26uOOAdHQi
0
4
7
🧬 L’equip de @RBDCOV_EU, un projecte europeu amb participació d'#IrsiCaixa, et convida a parlar sobre #COVID19, assaigs clínics i poblacions vulnerables mentre prenem un cafè! Apunta’t els detalls: 🗓️ 18 nov. 📍 Sala Segarra, @ateneubcn Inscriu-t'hi 👇 https://t.co/l5AnujVzHs
docs.google.com
Join us for an engaging discussion on the importance of inclusivity in clinical trials, focusing on key groups: immunocompromised individuals and pediatric populations. The event will take place on...
0
2
4
Who are the experts behind our upcoming #RBDCOV #ScienceCafé☕? Dr. @BeaMothe is the principal investigator of the HH-4 clinical trial for the COVID-19 vaccine, which focuses on individuals with immunosuppressive conditions. 🔴Register now to join us! 👉 https://t.co/PGYlLNcAA6
0
3
6
Vaccination remains the most effective way to protect from #COVID. 🔴That’s why at #RBDCOV, we are committed to developing inclusive and representative clinical trials. Read more in the article below! 🔽🔽
At least 1.6 million lives saved so far in the WHO/Europe Region thanks to #COVID19 vaccines among mainly older adults. Our new publication in @LancetRespirMed highlights the crucial role of vaccination amid the pandemic. But #COVID19 is ‘not over’. 🔗 https://t.co/LzGkvccONa
0
2
3
Designing clinical trials for children and adolescents requires careful consideration of their unique physiological and developmental needs. @Penta_ID key partner, ensures these are prioritised in the #RBDCOV project Read our latest specialized article👉 https://t.co/5cidXcJ63z
0
2
5
Read the full article by @EATGx with the #RBDCOV Community Advisory Panel and @Penta_ID How can we engage youth in Research & Development initiatives? 👉 https://t.co/RCLphmAMI1
📰 New #ReCAP Blog! 📰 💡 How can youth influence the future of R&D? Lungile Jafta (PENTA) and Maka Gogia (RBDCOV CAP) explore the challenges and solutions in involving young people in clinical trials. 👉 Read the full article: https://t.co/uagoG6INht
#YouthInResearch #RBDCOV
0
1
4
#RBDCOV in Figures 🔬 HH-3 Trial: Focused on the safety and immune response of a booster dose in adolescents aged 12 --18. 🔵200+ Participants 🔵Positive Preliminary Results #InnovationKillsTheVirus
0
2
5
Our latest article is out! 🥽🥼 Discover how @Penta_ID promotes health equity through inclusive clinical trials, focusing on the importance of including children to achieve widespread immunity. Read the full article🔴👉 https://t.co/CdqbiowGC9
#RBDCOV #InnovationKillsTheVirus
0
1
4
This might interest you! 🔴👉Some key steps that can help reduce the chance of severe #SARSCoV2 infection: #InnovationKillsTheVirus #RBDCOV
@WHO_Europe @EU_Health @SKyriakidesEU @SandraGallina @ECDC_EU @ECDC_Outbreaks @EPHA_EU @EUPHActs @JennyLeiRavelo @TheLancet @euronews @LongCFoundation @LongCovid_Spain @LongCovidAP @LongCOVIDEurope @mvankerkhove Key steps can help reduce the chance of severe #SARSCoV2 infection: ✅ Staying up-to-date with #COVID19 vaccines ✅ Ensuring quick access to antiviral treatment for people at high risk of severe illness ✅ Sensible precautions including: - masking for especially vulnerable
0
1
2